AMAG Pharmaceuticals, Inc. to Present at the 29th Annual J.P. Morgan Healthcare Conference by EON

VIEWS: 13 PAGES: 1

LEXINGTON, Mass.--(EON: Enhanced Online News)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that Brian J.G. Pereira, MD, President and CEO, will provide an update on the Company and the commercial launch of Feraheme® (ferumoxytol) Injection for intravenous (IV) use, at the 29th Annual J.P. Morgan Healthcare Conference on January 10, 2011 at 2:30 p.m. Pacific time. A live audio webcast of the company’s presentation and the following breakout session along with the accompanying slide a style='font-s

More Info
									AMAG Pharmaceuticals, Inc. to Present at the 29th
Annual J.P. Morgan Healthcare Conference
JPMorgan Healthcare Conference 2011
January 05, 2011 04:18 PM Eastern Time  

LEXINGTON, Mass.--(EON: Enhanced Online News)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG)
today announced that Brian J.G. Pereira, MD, President and CEO, will provide an update on the Company and the
commercial launch of Feraheme® (ferumoxytol) Injection for intravenous (IV) use, at the 29th Annual J.P. Morgan
Healthcare Conference on January 10, 2011 at 2:30 p.m. Pacific time.

A live audio webcast of the company’s presentation and the following breakout session along with the accompanying
slide presentation will be accessible through the Investors section of the Company’s website at
www.amagpharma.com. Following the conference, the webcast will be archived on the AMAG Pharmaceuticals,
Inc. website until February 10, 2011.

About AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes its proprietary technology for the
development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. AMAG
manufactures and sells Feraheme® (ferumoxytol) Injection for intravenous (IV) use. For additional company or
product information, please visit www.amagpharma.com or http://feraheme.com/.

Contacts
AMAG Pharmaceuticals, Inc.
Carol Miceli, 617-498-3361

Permalink: http://eon.businesswire.com/news/eon/20110105006726/en

								
To top